Overview of Bena Expectorant

Quick Facts

Property	Description
Active Ingredients	Diphenhydramine Hydrochloride, Ammonium Chloride, Sodium Citrate
Form	Oral Solution (Syrup)
Pharmacological Class	Expectorant, First-Generation Antihistamine
Common Use	Relief of productive cough and chest congestion
Origin	Synthetic and Inorganic Salts

What Type of Medicine is Bena Expectorant?

Bena Expectorant is a Fixed-Dose Combination (FDC) medication that is supplied as an Oral Solution (syrup) and administered via the oral route. It is fundamentally a Compound Preparation for respiratory symptom relief, strategically blending agents from two pharmacological categories: an expectorant and a first-generation antihistamine. The inclusion of Diphenhydramine Hydrochloride defines its dual role, which is clinically recognized for both its primary antihistaminic properties and its central, mild antitussive action.

Composition: The Active Ingredients of Bena Expectorant

The formulation contains three distinct active ingredients: Diphenhydramine Hydrochloride, Ammonium Chloride, and Sodium Citrate. Diphenhydramine Hydrochloride is the synthetic component that provides the cough-soothing effect, while the other two are inorganic salts used to influence secretions. The function of Ammonium Chloride as an expectorant agent is part of its pharmacological profile. The formulation also utilizes Sodium Citrate, which contributes a complementary mucolytic action, assisting in the thinning and breakdown of thick mucus. These active substances are delivered in an Aqueous Liquid Vehicle, typically a syrup base, to ensure consistent systemic absorption.

General Purpose and Therapeutic Profile

The medication's general purpose is to manage the characteristic discomfort of a productive cough complicated by chest congestion. This therapeutic profile is directed toward symptomatic relief during episodes like the common cold where excessive, stubborn phlegm is present. The formulation is engineered to achieve this by promoting the clearance of secretions via expectorant action and providing relief from the irritation that causes the persistent cough reflex.

What side effects are possible with Bena Expectorant?

Possible Side Effects and Safety Information

The officially documented safety profile for Bena Expectorant, a combination product containing Diphenhydramine, is categorized by the types and frequency of reported adverse reactions.

Frequency and System Classification

Adverse reactions are organized by System-Organ Class (SOC) and standard frequency categories documented in regulatory labeling. The most commonly reported effects are largely associated with the central nervous system (CNS) and anticholinergic properties of Diphenhydramine. Somnolence (sleepiness) is classified as a very common adverse reaction, which typically diminishes within a few days of treatment initiation.

Common adverse reactions listed in regulatory documents include dizziness, headache, dry mouth, nausea, vomiting, and disturbances in coordination or psychomotor impairment. Effects are documented across several systems, including the Gastrointestinal, Cardiovascular, Psychiatric, and Eye Disorders categories.

Serious Adverse Reactions and Population-Specific Safety

Official labels also document rare but serious adverse reactions, which include events such as convulsions, anaphylactic shock, and rare blood disorders, including agranulocytosis and hemolytic anemia.

Safety considerations are explicitly noted for specific populations. Elderly patients (60 years and older) are most likely to experience dizziness, sedation, and hypotension. Conversely, pediatric patients may experience the opposite effect, termed paradoxical excitation. Regulatory text also advises caution in individuals with pre-existing conditions such as narrow-angle glaucoma or moderate to severe hepatic (liver) or renal (kidney) dysfunction.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose involving Bena Expectorant is officially documented by regulatory authorities as potentially severe, primarily due to the Diphenhydramine Hydrochloride component. Documented overdose presentations affect the Central Nervous System and cardiovascular function. Manifestations may include pronounced drowsiness, agitation, tremor, and significant anticholinergic signs such as fixed or dilated pupils (mydriasis) and tachycardia.

The regulatory profile highlights the risk of life-threatening outcomes, including seizures, cardiovascular collapse, respiratory depression, and coma. Over-ingestion of the Ammonium Chloride component carries a specific risk of developing metabolic acidosis.

Immediate Action Mandated by Regulators

Official guidance is absolute: Seek immediate medical attention or contact emergency services immediately upon any suspected ingestion of excessive quantities. This urgent action is required if symptoms include unresponsiveness, hallucinations, difficulty breathing, or convulsions.

Management is defined as strictly symptomatic and supportive, often requiring procedures such as the administration of activated charcoal and continuous cardiac monitoring in a hospital setting. The official labeling confirms that no specific antidote is known.

Population-specific notes indicate that pediatric patients may experience greater CNS stimulation, while the elderly are more susceptible to severe anticholinergic effects.

Therapeutic Uses of Bena Expectorant

What Bena Expectorant Treats: Main Uses and Benefits

The medication is used in situations involving certain distressing symptoms related to the presence of thick, excess mucus.

Managing Chesty Cough and Related Mucus Symptoms

This section covers the medication’s role in managing productive or chesty cough and related symptoms associated with thick, sticky mucus. This provides support by easing symptoms related to the difficult-to-clear mucus, which contributes to a more manageable experience of coughing. The medication is applied in contexts where additional symptomatic support is needed, such as in conditions characterized by acute or disruptive respiratory episodes. This is commonly used to address symptoms of chest congestion and is relevant in contexts marked by increased discomfort or tension.

Easing Associated Congestion and Providing Comfort

The medication is commonly used to help with the associated symptoms of chest tightness and nasal blockage that occur due to respiratory secretions. This assists with easing symptoms that create noticeable physiological strain and contributes to improved comfort during symptomatic periods. The medication is relevant in contexts marked by increased discomfort, and may help patients cope more steadily with symptom fluctuations.

“It is relevant for easing symptoms related to physical discomfort, such as the feeling of heaviness or blockage.”

Quick Fact: Focus on Symptoms Related to Productive Cough

The medication is applied across domains where additional symptomatic support is needed, and contributes to easing the overall symptom load when manifestations are more noticeable.

Regulatory References

NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Bena Expectorant?

The eligibility for Bena Expectorant is determined by official regulatory criteria, primarily based on age, physiological status, and existing health conditions. This information is derived from government-approved product labels.

Populations Who Must Not Use Bena Expectorant (Contraindications)

The medicine is contraindicated and must not be used by the following groups:

Children under 2 years of age.
Nursing Mothers (Women who are breastfeeding).
Patients with known hypersensitivity to Diphenhydramine Hydrochloride or similar antihistamines.
Patients taking, or who have taken within the last 14 days, Monoamine Oxidase Inhibitors (MAOIs).

Populations Requiring Conditional Use (Caution)

Use requires caution and medical supervision in individuals with the following documented conditions:

Hepatic impairment (liver disease) or renal impairment (kidney disease).
Narrow-angle glaucoma or symptomatic prostatic hypertrophy.
Elderly patients (ge 60 years), due to increased susceptibility to effects like sedation.
Pregnant women; use is generally not recommended unless specifically advised by a physician.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of this medicine is defined by the properties of its three active components. This information is based solely on official regulatory documents.

Contraindicated and Restricted Combinations

Co-administration is restricted with Monoamine Oxidase Inhibitors (MAOIs), as these agents may prolong and intensify the anticholinergic effects of the Diphenhydramine component.

Pharmacodynamic and Additive Effects

Co-use with Alcohol and other Central Nervous System (CNS) Depressants (including sedatives and tranquilizers) results in officially documented additive CNS depression, increasing the effect of drowsiness. Combining this medicine with other anticholinergic agents may intensify those specific effects. Additionally, combining the Ammonium Chloride component with Dichlorphenamide carries a risk of additive systemic acidosis.

Exposure-Modifying Interactions

The Ammonium Chloride component acts as a urinary acidifying agent, a process that can decrease the plasma levels and effects of basic drugs like Amphetamine and its derivatives, including Pseudoephedrine, by increasing their renal clearance. Conversely, the Sodium Citrate component may lead to increased absorption and systemic exposure of co-administered Aluminum Hydroxide.

Population-Specific Cautions

For elderly patients (over approximately 60 years), the Diphenhydramine component is more likely to cause sedation and hypotension, making pharmacodynamic interactions more significant. Use is officially constrained in cases of severe hepatic or renal impairment due to the metabolic requirements of the Ammonium Chloride component.

Mechanism of Action

Bena Expectorant's pharmacodynamic profile is centered on its function as a mucoactive agent. The active expectorant component primarily exerts its effect via a neurogenic pathway. After systemic absorption, the compound is believed to act on vagal receptors located in the gastric mucosa of the gastrointestinal tract. Stimulation of these afferent receptors initiates a cholinergic parasympathetic reflex loop, which ultimately projects to the efferent secretomotor nerves of the respiratory tract.

This reflex cascade modulates the function of bronchial glands and respiratory tract epithelial cells, resulting in an increase in the volume and a concurrent decrease in the viscosity of fluid secretions within the bronchi and trachea. This alteration in rheological properties facilitates the mechanical transport of secretions by the ciliary epithelium toward the pharynx. The compound may also exhibit direct action on the respiratory epithelium to promote this reduction in secretion viscoelasticity.

Dosage and Administration Information

Official Administration Guidelines for Bena Expectorant

Bena Expectorant is an oral solution that must be used strictly according to the volume (mL) and frequency specified on the label to ensure correct administration. The official guidelines define use based on age, strict maximum doses, and proper procedural steps.

Dosing Schedule and Administration

The medicine is taken orally every 4 to 6 hours as needed. It must not be used in children under 2 years of age.

Age Group	Single Dose (Oral Solution)	Maximum Dose per 24 Hours
Adults and Children 12 years and over	5 mL to 10 mL	60 mL (12 teaspoons)
Children 6 to 12 years	2.5 mL to 5 mL	30 mL (6 teaspoons)
Children 2 to 5 years	2.5 mL	15 mL to 20 mL (3 to 4 teaspoons)

Procedural Steps

Measure Accurately: Use a proper dose-measuring device, such as a measuring spoon or oral syringe, to measure the exact milliliter (mL) dose required for the age group. A household spoon is not an accurate measuring tool.
Take with Water: The dose should be taken by mouth with a full glass of water. This product can be administered without regard to the timing of meals.
Do Not Exceed Limits: Do not take more than the maximum dose specified for the 24-hour period (e.g., 60 mL for adults).

Management of a Missed Dose

If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose must be skipped. Do not take a double dose to make up for a missed one.

Recent Clinical Evidence

Research evidence / Overview of studies for Bena Expectorant

Evidence for Use in Acute Cough Associated with Infections

This section will summarize the structure of Randomized Controlled Trials (RCTs) and Systematic Reviews that were conducted on the components of this medicine, focusing on what study outcomes monitored changes in cough frequency and severity in adults and adolescents with upper respiratory infections.

Research exploring this combination medicine and similar cough preparations typically involves short-term Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time by monitoring groups of Adults and Adolescents (12 years) who were experiencing acute cough symptoms, often relevant in common cold. Findings across the Systematic Reviews of over-the-counter combination products are often described as limited, with varying results across studies. This means research highlights changes measured during the study period, but data show patterns related to how patients reported their experience, rather than uniform, universal outcomes.

Evidence for Management of Excess Mucus and Congestion

This part will outline the type of Pharmacological and Clinical Research that exists for the expectorant and mucolytic components, detailing what studies examined regarding patient-reported symptom relief and assessments of mucus clearance properties.

The inclusion of expectorant and mucolytic components (Ammonium Chloride and Sodium Citrate) was evaluated in research exploring symptoms of chest congestion and excess phlegm. The research includes Pharmacological studies of the components which were evaluated by regulators during the review of the combination. However, scientific literature has noted that certainty remains low regarding the consistent, clinically meaningful effect of over-the-counter expectorants in managing acute cough. Evidence is limited regarding whether research has examined the expectorant components for changes in mucus clearance.

What is Still Uncertain About Bena Expectorant

This concluding section will synthesize the main research gaps, including areas where evidence remains inconsistent or limited, and highlight specific populations or conditions where more high-quality studies are needed to enhance the scientific understanding of the combination medicine.

Most of the research on these ingredients was conducted in Adults and Adolescents, and data for certain groups, such as Children (2 years), remain insufficient. Follow-up durations were typically limited to a few days, meaning long-term effects are not fully established. Certainty remains low regarding the overall consistency of the specific three-ingredient combination across different study settings.

Key Studies & References

Systemic review of randomized controlled trials of over the counter cough medicines for acute cough in adults

Frequently Asked Questions (FAQ)

Common questions about Bena Expectorant (FAQ)

Q: How quickly should I expect Bena Expectorant to start working on phlegm?

Official information indicates that the maximum concentration for the antihistamine component occurs in approximately one hour. However, regulatory documents do not specify the exact onset time for the combination product's intended action on loosening phlegm.

Q: What is the difference between Bena Expectorant and a cough suppressant (antitussive)?

Bena Expectorant is classified as an expectorant, meaning its primary role is to help you cough up mucus and clear your chest. It also contains an antihistamine, Diphenhydramine, which has a secondary effect that helps to suppress the cough reflex (antitussive action).

Q: Can Bena Expectorant also help clear a stuffy nose or nasal congestion?

The Diphenhydramine component is a first-generation antihistamine. This component may offer relief from symptoms like runny nose and post-nasal drip, which can be associated with congestion.

Q: Are there any common side effects related to the stomach, like nausea or abdominal pain?

According to official product information, common gastrointestinal side effects listed are nausea and vomiting. While not commonly listed, any persistent abdominal discomfort should be reported to a healthcare provider.

Q: How long does the drowsy effect of Bena Expectorant typically last?

The duration of activity for the Diphenhydramine component in the medicine is approximately four to six hours following a single dose. Due to the nature of the drug, the feeling of drowsiness or sedation may continue into the following day.

Q: Can I take Bena Expectorant if I am taking over-the-counter pain relievers (like ibuprofen or acetaminophen)?

Regulatory documents do not specifically list common pain relievers like ibuprofen or acetaminophen as known interactions. However, it is always best to consult a healthcare professional before combining medications.

Q: Does Bena Expectorant interact with any common herbal supplements?

Official interaction warnings are provided for other medicines, alcohol, and Central Nervous System (CNS) depressants. Regulatory documents do not typically contain specific interaction information regarding common herbal supplements.

Q: Can Bena Expectorant be used for chronic conditions like COPD or asthma, or only for short-term colds?

Bena Expectorant is generally intended for short-term use to relieve acute cough and congestion associated with conditions like the common cold. Official warnings advise consulting a doctor before use if you have a persistent or chronic cough, such as with asthma or chronic bronchitis.

Q: What should I do if my cough symptoms haven't improved after taking Bena Expectorant for several days?

Official warnings advise stopping use and consulting a doctor if cough symptoms last for more than seven days or if they are accompanied by new symptoms like fever or rash.

Q: Can the sodium citrate in Bena Expectorant cause any electrolyte concerns?

Sodium citrate is included in the medicine for its complementary mucolytic action. Official product information does not typically include warnings for general electrolyte imbalance concerns for this product.

Q: How long can I safely use Bena Expectorant before needing a break?

Regulatory warnings generally advise consulting a doctor if cough lasts more than seven days, as this medicine is not intended for chronic use.

Q: Can Bena Expectorant be taken with a cold medicine that contains a different active ingredient?

Warnings advise avoiding co-use with other medicines that cause sleepiness or have anticholinergic effects, in addition to products containing Diphenhydramine.

Q: Does Bena Expectorant help with coughs caused by post-nasal drip?

The medicine contains an antihistamine component, Diphenhydramine, which is effective at relieving symptoms such as a runny nose and post-nasal drip. This component may help to alleviate a cough associated with these symptoms.

Q: Does Bena Expectorant help with both wet and dry coughs?

The product is officially indicated for the relief of productive cough (a cough that produces mucus or phlegm) and associated chest congestion. However, the antihistamine component may also help suppress the cough reflex.

Q: Can Bena Expectorant be taken on an empty stomach?

Official administration instructions state that this product can be taken without any regard to the timing of meals.

Q: Is Bena Expectorant gluten-free or suitable for people with specific dietary restrictions?

Regulatory documents list the active and inactive ingredients. However, official product labeling does not typically certify a product as 'gluten-free' or list other specific dietary restrictions.

Q: Is Bena Expectorant available in tablet form, or only as a syrup/liquid?

Official product labeling for Bena Expectorant describes it as an Oral Solution, which is a liquid or syrup form.

Q: Does the fruity flavor in Bena Expectorant affect its effectiveness?

The flavoring in the syrup is an inactive ingredient. The effectiveness of the medicine in loosening phlegm and suppressing cough is strictly due to the three active ingredients and their pharmacological action.

Q: Are there any known interactions between Bena Expectorant and caffeine?

Regulatory documents do not specifically list an interaction with caffeine. Warnings focus on avoiding use with Central Nervous System (CNS) depressants due to the risk of increased sedation.

Q: Does Bena Expectorant contain pseudoephedrine or other stimulants?

According to official documents, the active ingredients in Bena Expectorant are Diphenhydramine Hydrochloride, Ammonium Chloride, and Sodium Citrate. It does not contain pseudoephedrine or other stimulants.

Q: What are the signs that Bena Expectorant is starting to work in the lungs/chest?

The intended effect of the expectorant component is to thin bronchial secretions and increase their volume. This is designed to make the phlegm easier to cough out, which should result in a more productive cough and relief from chest congestion.

Q: Does Bena Expectorant contain alcohol?

The alcohol content of a liquid medicine is typically listed in the inactive ingredients section of the official label. It is recommended to check the product packaging for a specific confirmation of any alcohol content.

Q: Are there any specific lifestyle changes that should be made while taking Bena Expectorant?

Official warnings specifically advise avoiding alcoholic beverages while taking the medicine due to the increased risk of drowsiness. No other general lifestyle advice is typically provided in the regulatory text.

Q: Why is there a maximum daily limit for Bena Expectorant intake?

The maximum daily limit is set by regulatory bodies to prevent overdose, which can cause severe adverse symptoms affecting the central nervous system.

Q: Are there different versions or strengths of Bena Expectorant available?

Official product information only specifies one fixed-dose combination and strength for this particular Bena Expectorant product in its oral solution form.

Q: What does 'loosen stubborn phlegm' mean in the context of Bena Expectorant?

This common phrase refers to the medicine’s action of making the mucus in your respiratory tract less thick. The expectorant component works to decrease the viscosity of the phlegm while increasing its volume, making it easier to cough up and clear.

How should Bena Expectorant be stored and disposed of?

Official Storage and Handling

Bena Expectorant oral solution must be stored strictly according to official regulatory documentation to maintain product stability and potency. The required storage temperature is below 30 C or at controlled room temperature.

Storage Requirement	Specification
Temperature	Below 30 C (Do not freeze)
Protection	Protect from light and excessive moisture
Container	Keep in original container and keep tightly closed

It is officially mandated that the medicine be stored out of the sight and reach of children and pets, and safety caps must always be secured.

Disposal Requirements

Disposal of unused or expired Bena Expectorant must adhere to local regulatory requirements. The product should not be flushed down a toilet or poured down a drain. If a drug take-back program is unavailable, the unused medicine should be mixed with an undesirable substance, placed in a sealed container, and then discarded in the household trash, following FDA guidance.

Bena Expectorant